APO Research
Talk to an analyst

APO RESEARCH · REPORT

Hemostatic Gel

Hemostatic gel is used as an adjunct or alternative to standard suture techniques to control bleeding or wound closure.In recent years, global hemostatic gels have developed rapidly, with an average growth rate of around 7%.In 2018, global production of hemostatic gels was about 3.26 million pieces.In 2018, China accounted for about 3 percent of global sales.In the next five years, China's hemostatic gel products will continue to grow rapidly.Hemostatic gels are mainly divided into fibrin, gelatin and others, among which fibrin accounts for the largest proportion, accounting for nearly 38% of the total market in 2018, while gelatin accounts for 28%.Hemostatic gels are mainly used in minimally invasive surgery, general surgery and other aspects, among which minimally invasive surgery is the main application field, accounting for 51% in 2018 and general surgery for 28%.Hemostatic gels are mainly divided into fibrin, gelatin and others, among which fibrin accounts for the largest proportion, accounting for nearly 38% of the total market in 2018, while gelatin accounts for 28%.Hemostatic gels are mainly used in minimally invasive surgery, general surgery and other aspects, among which minimally invasive surgery is the main application field, accounting for 51% in 2018 and general surgery for 28%.Baxter, J&J, CryoLife, Integra Life Sciences are major suppliers.These suppliers have mastered key technologies and patents, and have a fixed customer base, which has formed a monopoly situation in the market.The growth of the elderly population and the increasing prevalence of chronic diseases are the driving factors affecting the industry.More than 45 percent of americans have at least one chronic condition that requires intensive care, according to the CDC.Elderly patients require intensive care, are prone to injury and take a long time to heal.Chronic diseases eventually led to surgery, which in turn spurred the development of the hemostatic gel industry.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Hemostatic gel is used as an adjunct or alternative to standard suture techniques to control bleeding or wound closure.In recent years, global hemostatic gels have developed rapidly, with an average growth rate of around 7%.In 2018, global production of hemostatic gels was about 3.26 million pieces.In 2018, China accounted for about 3 percent of global sales.In the next five years, China's hemostatic gel products will continue to grow rapidly.Hemostatic gels are mainly divided into fibrin, gelatin and others, among which fibrin accounts for the largest proportion, accounting for nearly 38% of the total market in 2018, while gelatin accounts for 28%.Hemostatic gels are mainly used in minimally invasive surgery, general surgery and other aspects, among which minimally invasive surgery is the main application field, accounting for 51% in 2018 and general surgery for 28%.Hemostatic gels are mainly divided into fibrin, gelatin and others, among which fibrin accounts for the largest proportion, accounting for nearly 38% of the total market in 2018, while gelatin accounts for 28%.Hemostatic gels are mainly used in minimally invasive surgery, general surgery and other aspects, among which minimally invasive surgery is the main application field, accounting for 51% in 2018 and general surgery for 28%.Baxter, J&J, CryoLife, Integra Life Sciences are major suppliers.These suppliers have mastered key technologies and patents, and have a fixed customer base, which has formed a monopoly situation in the market.The growth of the elderly population and the increasing prevalence of chronic diseases are the driving factors affecting the industry.More than 45 percent of americans have at least one chronic condition that requires intensive care, according to the CDC.Elderly patients require intensive care, are prone to injury and take a long time to heal.Chronic diseases eventually led to surgery, which in turn spurred the development of the hemostatic gel industry.

Selected research

Industry Research

Hemostatic Gel Industry Research Report 2026

27 December 2025121 pages

Choose your research edition.

Industry ResearchHemostatic Gel Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Hemostatic Gel Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Hemostatic Gel Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Hemostatic Gel Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Hemostatic Gel Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

Hemostatic gel is used as an adjunct or alternative to standard suture techniques to control bleeding or wound closure.In recent years, global hemostatic gels have developed rapidly, with an average growth rate of around 7%.In 2018, global production of hemostatic gels was about 3.26 million pieces.In 2018, China accounted for about 3 percent of global sales.In the next five years, China's hemostatic gel products will continue to grow rapidly.Hemostatic gels are mainly divided into fibrin, gelatin and others, among which fibrin accounts for the largest proportion, accounting for nearly 38% of the total market in 2018, while gelatin accounts for 28%.Hemostatic gels are mainly used in minimally invasive surgery, general surgery and other aspects, among which minimally invasive surgery is the main application field, accounting for 51% in 2018 and general surgery for 28%.Hemostatic gels are mainly divided into fibrin, gelatin and others, among which fibrin accounts for the largest proportion, accounting for nearly 38% of the total market in 2018, while gelatin accounts for 28%.Hemostatic gels are mainly used in minimally invasive surgery, general surgery and other aspects, among which minimally invasive surgery is the main application field, accounting for 51% in 2018 and general surgery for 28%.Baxter, J&J, CryoLife, Integra Life Sciences are major suppliers.These suppliers have mastered key technologies and patents, and have a fixed customer base, which has formed a monopoly situation in the market.The growth of the elderly population and the increasing prevalence of chronic diseases are the driving factors affecting the industry.More than 45 percent of americans have at least one chronic condition that requires intensive care, according to the CDC.Elderly patients require intensive care, are prone to injury and take a long time to heal.Chronic diseases eventually led to surgery, which in turn spurred the development of the hemostatic gel industry.

Global Hemostatic Gel key players include Baxter, J&J, Advance Medical Solution, etc. Global top three manufacturers hold a share over 45%.

North America is the largest market, with a share over 60%, followed by Europe, with a share over 20 percent.

Read the full market overview

In terms of product, Fibrin is the largest segment, with a share over 35%. And in terms of application, the largest application is Minimally Invasive Surgery, followed by General Surgery, etc.

Report Scope

This report quantifies the global Hemostatic Gel market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Hemostatic Gel Market by Company

Baxter

J&J

CryoLife

Integra Life Sciences

Advance Medical Solution

BD

CSL Behring

Pfizer

B Braun

Hemostatic Gel Segment by Type

Fibrin

Gelatin

Other

Hemostatic Gel Segment by Application

Minimally Invasive Surgery

General Surgery

Others

Hemostatic Gel Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hemostatic Gel market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hemostatic Gel and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hemostatic Gel.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Hemostatic Gel manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Hemostatic Gel by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Hemostatic Gel in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Hemostatic Gel Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Hemostatic Gel Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Hemostatic Gel Sales Market Share by Manufacturers (2021-2026) Table 8. Global Hemostatic Gel Revenue of Manufacturers (2021-2026) Table 9. Global Hemostatic Gel Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Hemostatic Gel Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Hemostatic Gel Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Hemostatic Gel, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Hemostatic Gel, Product Type & Application Table 14. Global Hemostatic Gel Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Hemostatic Gel by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Baxter Company Information Table 19. Baxter Business Overview Table 20. Baxter Hemostatic Gel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Baxter Hemostatic Gel Product Portfolio Table 22. Baxter Recent Developments Table 23. J&J Company Information Table 24. J&J Business Overview Table 25. J&J Hemostatic Gel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. J&J Hemostatic Gel Product Portfolio Table 27. J&J Recent Developments Table 28. CryoLife Company Information Table 29. CryoLife Business Overview Table 30. CryoLife Hemostatic Gel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. CryoLife Hemostatic Gel Product Portfolio Table 32. CryoLife Recent Developments Table 33. Integra Life Sciences Company Information Table 34. Integra Life Sciences Business Overview Table 35. Integra Life Sciences Hemostatic Gel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Integra Life Sciences Hemostatic Gel Product Portfolio Table 37. Integra Life Sciences Recent Developments Table 38. Advance Medical Solution Company Information Table 39. Advance Medical Solution Business Overview Table 40. Advance Medical Solution Hemostatic Gel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Advance Medical Solution Hemostatic Gel Product Portfolio Table 42. Advance Medical Solution Recent Developments Table 43. BD Company Information Table 44. BD Business Overview Table 45. BD Hemostatic Gel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. BD Hemostatic Gel Product Portfolio Table 47. BD Recent Developments Table 48. CSL Behring Company Information Table 49. CSL Behring Business Overview Table 50. CSL Behring Hemostatic Gel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. CSL Behring Hemostatic Gel Product Portfolio Table 52. CSL Behring Recent Developments Table 53. Pfizer Company Information Table 54. Pfizer Business Overview Table 55. Pfizer Hemostatic Gel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Pfizer Hemostatic Gel Product Portfolio Table 57. Pfizer Recent Developments Table 58. B Braun Company Information Table 59. B Braun Business Overview Table 60. B Braun Hemostatic Gel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. B Braun Hemostatic Gel Product Portfolio Table 62. B Braun Recent Developments Table 63. Global Hemostatic Gel Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 64. Global Hemostatic Gel Sales by Region (2021-2026) & (K Units) Table 65. Global Hemostatic Gel Sales Market Share by Region (2021-2026) Table 66. Global Hemostatic Gel Sales by Region (2027-2032) & (K Units) Table 67. Global Hemostatic Gel Sales Market Share by Region (2027-2032) Table 68. Global Hemostatic Gel Revenue by Region (2021-2026) & (US$ Million) Table 69. Global Hemostatic Gel Revenue Market Share by Region (2021-2026) Table 70. Global Hemostatic Gel Revenue by Region (2027-2032) & (US$ Million) Table 71. Global Hemostatic Gel Revenue Market Share by Region (2027-2032) Table 72. North America Hemostatic Gel Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 73. North America Hemostatic Gel Sales by Country (2021-2026) & (K Units) Table 74. North America Hemostatic Gel Sales by Country (2027-2032) & (K Units) Table 75. North America Hemostatic Gel Revenue by Country (2021-2026) & (US$ Million) Table 76. North America Hemostatic Gel Revenue by Country (2027-2032) & (US$ Million) Table 77. Europe Hemostatic Gel Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 78. Europe Hemostatic Gel Sales by Country (2021-2026) & (K Units) Table 79. Europe Hemostatic Gel Sales by Country (2027-2032) & (K Units) Table 80. Europe Hemostatic Gel Revenue by Country (2021-2026) & (US$ Million) Table 81. Europe Hemostatic Gel Revenue by Country (2027-2032) & (US$ Million) Table 82. Asia Pacific Hemostatic Gel Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 83. Asia Pacific Hemostatic Gel Sales by Country (2021-2026) & (K Units) Table 84. Asia Pacific Hemostatic Gel Sales by Country (2027-2032) & (K Units) Table 85. Asia Pacific Hemostatic Gel Revenue by Country (2021-2026) & (US$ Million) Table 86. Asia Pacific Hemostatic Gel Revenue by Country (2027-2032) & (US$ Million) Table 87. South America Hemostatic Gel Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 88. South America Hemostatic Gel Sales by Country (2021-2026) & (K Units) Table 89. South America Hemostatic Gel Sales by Country (2027-2032) & (K Units) Table 90. South America Hemostatic Gel Revenue by Country (2021-2026) & (US$ Million) Table 91. South America Hemostatic Gel Revenue by Country (2027-2032) & (US$ Million) Table 92. Middle East and Africa Hemostatic Gel Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 93. Middle East and Africa Hemostatic Gel Sales by Country (2021-2026) & (K Units) Table 94. Middle East and Africa Hemostatic Gel Sales by Country (2027-2032) & (K Units) Table 95. Middle East and Africa Hemostatic Gel Revenue by Country (2021-2026) & (US$ Million) Table 96. Middle East and Africa Hemostatic Gel Revenue by Country (2027-2032) & (US$ Million) Table 97. Global Hemostatic Gel Sales by Type (2021-2026) & (K Units) Table 98. Global Hemostatic Gel Sales by Type (2027-2032) & (K Units) Table 99. Global Hemostatic Gel Sales Market Share by Type (2021-2026) Table 100. Global Hemostatic Gel Sales Market Share by Type (2027-2032) Table 101. Global Hemostatic Gel Revenue by Type (2021-2026) & (US$ Million) Table 102. Global Hemostatic Gel Revenue by Type (2027-2032) & (US$ Million) Table 103. Global Hemostatic Gel Revenue Market Share by Type (2021-2026) Table 104. Global Hemostatic Gel Revenue Market Share by Type (2027-2032) Table 105. Global Hemostatic Gel Price by Type (2021-2026) & (US$/Unit) Table 106. Global Hemostatic Gel Price by Type (2027-2032) & (US$/Unit) Table 107. Global Hemostatic Gel Sales by Application (2021-2026) & (K Units) Table 108. Global Hemostatic Gel Sales by Application (2027-2032) & (K Units) Table 109. Global Hemostatic Gel Sales Market Share by Application (2021-2026) Table 110. Global Hemostatic Gel Sales Market Share by Application (2027-2032) Table 111. Global Hemostatic Gel Revenue by Application (2021-2026) & (US$ Million) Table 112. Global Hemostatic Gel Revenue by Application (2027-2032) & (US$ Million) Table 113. Global Hemostatic Gel Revenue Market Share by Application (2021-2026) Table 114. Global Hemostatic Gel Revenue Market Share by Application (2027-2032) Table 115. Global Hemostatic Gel Price by Application (2021-2026) & (US$/Unit) Table 116. Global Hemostatic Gel Price by Application (2027-2032) & (US$/Unit) Table 117. Key Raw Materials Table 118. Raw Materials Key Suppliers Table 119. Hemostatic Gel Distributors List Table 120. Hemostatic Gel Customers List Table 121. Hemostatic Gel Industry Trends Table 122. Hemostatic Gel Industry Drivers Table 123. Hemostatic Gel Industry Restraints Table 124. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Hemostatic Gel Product Image Figure 5. Global Hemostatic Gel Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Hemostatic Gel Market Size (2021-2032) & (US$ Million) Figure 7. Global Hemostatic Gel Sales (2021-2032) & (K Units) Figure 8. Global Hemostatic Gel Average Price (US$/Unit) & (2021-2032) Figure 9. Fibrin Product Image Figure 10. Gelatin Product Image Figure 11. Other Product Image Figure 12. Minimally Invasive Surgery Product Image Figure 13. General Surgery Product Image Figure 14. Others Product Image Figure 15. Global Hemostatic Gel Revenue Share by Manufacturers in 2025 Figure 16. Global Manufacturers of Hemostatic Gel, Manufacturing Sites & Headquarters Figure 17. Global Top 5 and 10 Hemostatic Gel Players Market Share by Revenue in 2025 Figure 18. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Hemostatic Gel Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 20. Global Hemostatic Gel Sales by Region in 2025 Figure 21. Global Hemostatic Gel Revenue by Region in 2025 Figure 22. North America Hemostatic Gel Market Size by Country in 2025 Figure 23. North America Hemostatic Gel Sales Market Share by Country (2021-2032) Figure 24. North America Hemostatic Gel Revenue Market Share by Country (2021-2032) Figure 25. United States Hemostatic Gel Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Canada Hemostatic Gel Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Mexico Hemostatic Gel Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Europe Hemostatic Gel Market Size by Country in 2025 Figure 29. Europe Hemostatic Gel Sales Market Share by Country (2021-2032) Figure 30. Europe Hemostatic Gel Revenue Market Share by Country (2021-2032) Figure 31. Germany Hemostatic Gel Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. France Hemostatic Gel Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. U.K. Hemostatic Gel Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Italy Hemostatic Gel Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Russia Hemostatic Gel Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Spain Hemostatic Gel Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Netherlands Hemostatic Gel Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Switzerland Hemostatic Gel Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Sweden Hemostatic Gel Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Poland Hemostatic Gel Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Asia Pacific Hemostatic Gel Market Size by Country in 2025 Figure 42. Asia Pacific Hemostatic Gel Sales Market Share by Country (2021-2032) Figure 43. Asia Pacific Hemostatic Gel Revenue Market Share by Country (2021-2032) Figure 44. China Hemostatic Gel Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. Japan Hemostatic Gel Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. South Korea Hemostatic Gel Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. India Hemostatic Gel Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Australia Hemostatic Gel Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Taiwan Hemostatic Gel Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Southeast Asia Hemostatic Gel Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Southeast Asia Hemostatic Gel Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. South America Hemostatic Gel Market Size by Country in 2025 Figure 53. South America Hemostatic Gel Sales Market Share by Country (2021-2032) Figure 54. South America Hemostatic Gel Revenue Market Share by Country (2021-2032) Figure 55. Brazil Hemostatic Gel Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Argentina Hemostatic Gel Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Chile Hemostatic Gel Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Middle East and Africa Hemostatic Gel Market Size by Country in 2025 Figure 59. Middle East and Africa Hemostatic Gel Sales Market Share by Country (2021-2032) Figure 60. Middle East and Africa Hemostatic Gel Revenue Market Share by Country (2021-2032) Figure 61. Egypt Hemostatic Gel Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. South Africa Hemostatic Gel Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Israel Hemostatic Gel Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Türkiye Hemostatic Gel Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. GCC Countries Hemostatic Gel Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. Global Hemostatic Gel Sales Market Share by Type (2021-2032) Figure 67. Global Hemostatic Gel Revenue Market Share by Type (2021-2032) Figure 68. Global Hemostatic Gel Price (US$/Unit) by Type (2021-2032) Figure 69. Global Hemostatic Gel Sales Market Share by Application (2021-2032) Figure 70. Global Hemostatic Gel Revenue Market Share by Application (2021-2032) Figure 71. Global Hemostatic Gel Price (US$/Unit) by Application (2021-2032) Figure 72. Hemostatic Gel Value Chain Figure 73. Hemostatic Gel Production Mode & Process Figure 74. Direct Comparison with Distribution Share Figure 75. Distributors Profiles Figure 76. Hemostatic Gel Industry Opportunities and Challenges

Scope & coverage.

Types
  • Fibrin
  • Gelatin
  • Other
Applications
  • Minimally Invasive Surgery
  • General Surgery
  • Others
Companies covered
  • Baxter
  • J&J
  • CryoLife
  • Integra Life Sciences
  • Advance Medical Solution
  • BD
  • CSL Behring
  • Pfizer
  • B Braun

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Hemostatic Gel Market Size (2021-2032)
  4. 2.2.2 Global Hemostatic Gel Sales (2021-2032)
  5. 2.2.3 Global Hemostatic Gel Market Average Price (2021-2032)
  6. 2.3 Hemostatic Gel by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Fibrin
  9. 2.3.3 Gelatin
  10. 2.3.4 Other
  11. 2.4 Hemostatic Gel by Application
  12. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  13. 2.4.2 Minimally Invasive Surgery
  14. 2.4.3 General Surgery
  15. 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Hemostatic Gel Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Hemostatic Gel Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Hemostatic Gel Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Hemostatic Gel Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Hemostatic Gel Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Hemostatic Gel, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Hemostatic Gel, Product Type & Application
  8. 3.8 Global Manufacturers of Hemostatic Gel, Established Date
  9. 3.9 Global Hemostatic Gel Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Baxter
  2. 4.1.1 Baxter Company Information
  3. 4.1.2 Baxter Business Overview
  4. 4.1.3 Baxter Hemostatic Gel Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Baxter Hemostatic Gel Product Portfolio
  6. 4.1.5 Baxter Recent Developments
  7. 4.2 J&J
  8. 4.2.1 J&J Company Information
  9. 4.2.2 J&J Business Overview
  10. 4.2.3 J&J Hemostatic Gel Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 J&J Hemostatic Gel Product Portfolio
  12. 4.2.5 J&J Recent Developments
  13. 4.3 CryoLife
  14. 4.3.1 CryoLife Company Information
  15. 4.3.2 CryoLife Business Overview
  16. 4.3.3 CryoLife Hemostatic Gel Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 CryoLife Hemostatic Gel Product Portfolio
  18. 4.3.5 CryoLife Recent Developments
  19. 4.4 Integra Life Sciences
  20. 4.4.1 Integra Life Sciences Company Information
  21. 4.4.2 Integra Life Sciences Business Overview
  22. 4.4.3 Integra Life Sciences Hemostatic Gel Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Integra Life Sciences Hemostatic Gel Product Portfolio
  24. 4.4.5 Integra Life Sciences Recent Developments
  25. 4.5 Advance Medical Solution
  26. 4.5.1 Advance Medical Solution Company Information
  27. 4.5.2 Advance Medical Solution Business Overview
  28. 4.5.3 Advance Medical Solution Hemostatic Gel Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Advance Medical Solution Hemostatic Gel Product Portfolio
  30. 4.5.5 Advance Medical Solution Recent Developments
  31. 4.6 BD
  32. 4.6.1 BD Company Information
  33. 4.6.2 BD Business Overview
  34. 4.6.3 BD Hemostatic Gel Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 BD Hemostatic Gel Product Portfolio
  36. 4.6.5 BD Recent Developments
  37. 4.7 CSL Behring
  38. 4.7.1 CSL Behring Company Information
  39. 4.7.2 CSL Behring Business Overview
  40. 4.7.3 CSL Behring Hemostatic Gel Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 CSL Behring Hemostatic Gel Product Portfolio
  42. 4.7.5 CSL Behring Recent Developments
  43. 4.8 Pfizer
  44. 4.8.1 Pfizer Company Information
  45. 4.8.2 Pfizer Business Overview
  46. 4.8.3 Pfizer Hemostatic Gel Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Pfizer Hemostatic Gel Product Portfolio
  48. 4.8.5 Pfizer Recent Developments
  49. 4.9 B Braun
  50. 4.9.1 B Braun Company Information
  51. 4.9.2 B Braun Business Overview
  52. 4.9.3 B Braun Hemostatic Gel Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 B Braun Hemostatic Gel Product Portfolio
  54. 4.9.5 B Braun Recent Developments
5 Global Hemostatic Gel Market Scenario by Region
  1. 5.1 Global Hemostatic Gel Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Hemostatic Gel Sales by Region: 2021-2032
  3. 5.2.1 Global Hemostatic Gel Sales by Region: 2021-2026
  4. 5.2.2 Global Hemostatic Gel Sales by Region: 2027-2032
  5. 5.3 Global Hemostatic Gel Revenue by Region: 2021-2032
  6. 5.3.1 Global Hemostatic Gel Revenue by Region: 2021-2026
  7. 5.3.2 Global Hemostatic Gel Revenue by Region: 2027-2032
  8. 5.4 North America Hemostatic Gel Market Facts & Figures by Country
  9. 5.4.1 North America Hemostatic Gel Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Hemostatic Gel Sales by Country (2021-2032)
  11. 5.4.3 North America Hemostatic Gel Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Hemostatic Gel Market Facts & Figures by Country
  16. 5.5.1 Europe Hemostatic Gel Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Hemostatic Gel Sales by Country (2021-2032)
  18. 5.5.3 Europe Hemostatic Gel Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Hemostatic Gel Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Hemostatic Gel Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Hemostatic Gel Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Hemostatic Gel Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Hemostatic Gel Market Facts & Figures by Country
  41. 5.7.1 South America Hemostatic Gel Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Hemostatic Gel Sales by Country (2021-2032)
  43. 5.7.3 South America Hemostatic Gel Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Hemostatic Gel Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Hemostatic Gel Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Hemostatic Gel Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Hemostatic Gel Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Hemostatic Gel Sales by Type (2021-2032)
  2. 6.1.1 Global Hemostatic Gel Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Hemostatic Gel Sales Market Share by Type (2021-2032)
  4. 6.2 Global Hemostatic Gel Revenue by Type (2021-2032)
  5. 6.2.1 Global Hemostatic Gel Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Hemostatic Gel Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Hemostatic Gel Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Hemostatic Gel Sales by Application (2021-2032)
  2. 7.1.1 Global Hemostatic Gel Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Hemostatic Gel Sales Market Share by Application (2021-2032)
  4. 7.2 Global Hemostatic Gel Revenue by Application (2021-2032)
  5. 7.2.1 Global Hemostatic Gel Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Hemostatic Gel Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Hemostatic Gel Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Hemostatic Gel Value Chain Analysis
  2. 8.1.1 Hemostatic Gel Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Hemostatic Gel Production Mode & Process
  5. 8.2 Hemostatic Gel Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Hemostatic Gel Distributors
  8. 8.2.3 Hemostatic Gel Customers
9 Global Hemostatic Gel Analyzing Market Dynamics
  1. 9.1 Hemostatic Gel Industry Trends
  2. 9.2 Hemostatic Gel Industry Drivers
  3. 9.3 Hemostatic Gel Industry Opportunities and Challenges
  4. 9.4 Hemostatic Gel Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst